In prostate cancer, Lu et al. utilized RNA interference technology to downregulate GRP78 and GRP74 expression in the PC-3 cell line, and this result in reduced cell migration and induction of apoptosis(Lu et al. 2019). This evidence concerns the gene HSPA5 and prostate carcinoma.